Article
Primary glioblastoma with oligodendroglial differentiation has better clinical outcome but no difference in common biological markers compared with other types of glioblastoma.
Neuro-oncology - 1 Dec 2013
Laxton Ross C, Popov Sergey, Doey Lawrence, Jury Alexa, Bhangoo Ranj, Gullan Richard, Chandler Chris, Brazil Lucy, Sadler Gill, Beaney Ron, Sibtain Naomi, King Andrew, Bodi Istvan, Jones Chris, Ashkan Keyoumars, Al-Sarraj Safa
Abstract excerpt
BACKGROUND: Glioblastoma multiforme with an oligodendroglial component (GBMO) has been recognized in the World Health Organization classification-however, the diagnostic criteria, molecular biology, and clinical outcome of primary GBMO remain unclear. Our aim was to investigate whether primary GBMO is a distinct clinicopathological subgroup of GBM and to determine the relative frequency of prognostic markers such...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.